Physician profile

Angela Murphy

Family · Jermyn, PA

NPI 1093229189

$515.30

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$305.93

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $245.33 2021-2024 Coroflow, Xience Sierra
Pfizer INC. $72.33 2021-2023
Dexcom, INC. $36.88 2022
Novo Nordisk INC $30.52 2023 Wegovy
Abbvie INC. $29.15 2021
Amgen INC. $28.75 2021
Janssen Pharmaceuticals, INC $26.07 2023 Invega Sustenna
Glaxosmithkline, LLC. $19.88 2023 Bexsero
Indivior INC. $17.73 2023 Sublocade
Neuronetics, INC. $8.66 2023 Neurostar Tms Therapy System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Angela Murphy

$515.30

in general payments reported 2019-2025

Years
2021-2024
Top company
Abbott Laboratories

https://glasscript.com/doctor/10532607/angela-murphy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.